methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2
Published February 4, 2026 · Recall initiated: January 15, 2026
Summary
FDA records drug Class II recall D-0299-2026, published February 4, 2026 and initiated January 15, 2026. Recalling firm: Greenstone Llc; Status: Ongoing; Reported quantity: 3456 cartons; Lot: Lot # LG7675, Exp. Date Nov 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
What to do
Voluntary: Firm initiated · Letter
Get an email if METHYLPREDNISOLONE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- METHYLPREDNISOLONE
- Manufacturer
- Greenstone Llc
- Distributor
- Nationwide within the United States
- UPC
- 0359762005014
- Lot
- Lot # LG7675, Exp. Date Nov 2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAINON ACE Antacid tablets (magnesium aluminosilicate, magnesium hydroxide and simethicone), 75-count bottle,February 4, 2026
- FDAGlycopyrrolate Oral Solution, 1 mg/5 mL, 16 oz. (473 mL), Rx only, Manufactured by: MSN Pharmaceuticals Inc.,February 4, 2026
- FDAMethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad,June 26, 2019
- FDAMethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad,June 26, 2019
- FDAMethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad,June 26, 2019
- FDAMethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by:June 26, 2019
Questions about this recall
Was methylprednisolone tablets, USP Dosepak, 4 mg, 1 Blister Card per Carton containing 21 Tablets, Rx only, Distributed by: Greenstone LLC, Peapack, NJ 07977. NDC 59762-4440-2 recalled?
Yes. FDA published recall D-0299-2026 on February 4, 2026. Reported hazard: Labeling: Not Elsewhere Classified. Incorrect orientation of the blister foil applied to the blister cavities, which results in incorrect dosing information when following the directions on the foil.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: METHYLPREDNISOLONE. UPC: 0359762005014.